• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

胆管癌的最新进展

Updates in Cholangiocarcinoma.

作者信息

O'Hagan Kristen

机构信息

Memorial Sloan Kettering Cancer Center, New York, New York.

出版信息

J Adv Pract Oncol. 2022 Apr;13(3):320-323. doi: 10.6004/jadpro.2022.13.3.28. Epub 2022 May 23.

DOI:10.6004/jadpro.2022.13.3.28
PMID:35663158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9126342/
Abstract

Cholangiocarcinoma is a spectrum of invasive adenocarcinomas that arise in the intrahepatic, perihilar, or distal biliary tree, and is classified by location. During JADPRO Live Virtual 2021, Kristen O'Hagan, MSN, RN, ANP-BC, AOCNP®, discussed this complex disease, current treatment strategies, and the role of targeted therapy and how it's changing the treatment landscape for cholangiocarcinoma.

摘要

胆管癌是一种侵袭性腺癌，发生于肝内、肝门周围或远端胆管树，并根据位置进行分类。在2021年JADPRO现场虚拟会议期间，拥有护理学硕士学位、注册护士、成人护理执业护士 - 认证委员会认证、高级肿瘤护理执业护士资格的克里斯汀·奥黑根讨论了这种复杂的疾病、当前的治疗策略、靶向治疗的作用以及它如何改变胆管癌的治疗格局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5063/9126342/b776171d7740/jadpro-13-320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5063/9126342/b776171d7740/jadpro-13-320-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5063/9126342/b776171d7740/jadpro-13-320-g001.jpg

相似文献

1
Updates in Cholangiocarcinoma.胆管癌的最新进展
J Adv Pract Oncol. 2022 Apr;13(3):320-323. doi: 10.6004/jadpro.2022.13.3.28. Epub 2022 May 23.
2
Infrequent Offenders: Neuroendocrine Tumors and Cancers of the Appendix, Gallbladder, and Bile Duct.罕见肿瘤：阑尾、胆囊和胆管的神经内分泌肿瘤及癌症
J Adv Pract Oncol. 2021 Apr;12(3):315-318. doi: 10.6004/jadpro.2021.12.3.20. Epub 2021 Apr 1.
3
Diagnosis and Treatment of AL and ATTR Amyloidosis.AL型和ATTR型淀粉样变性的诊断与治疗
J Adv Pract Oncol. 2021 Apr;12(3):329-332. doi: 10.6004/jadpro.2021.12.3.24. Epub 2021 Apr 1.
4
The Advanced Practice Role in Clinical Trials: Past, Present, and Future.临床试验中的高级实践角色：过去、现在与未来。
J Adv Pract Oncol. 2022 Apr;13(3):217-220. doi: 10.6004/jadpro.2022.13.3.7. Epub 2022 May 23.
5
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.胆管癌。包括一系列肝内、肝门周围和远端肿瘤。
Ann Surg. 1996 Oct;224(4):463-73; discussion 473-5. doi: 10.1097/00000658-199610000-00005.
6
Immunotherapy for the Treatment of Triple-Negative Breast Cancer.三阴性乳腺癌治疗的免疫疗法
J Adv Pract Oncol. 2022 Apr;13(3):298-301. doi: 10.6004/jadpro.2022.13.3.23. Epub 2022 May 23.
7
Anatomical, histomorphological and molecular classification of cholangiocarcinoma.胆管癌的解剖学、组织形态学和分子分类。
Liver Int. 2019 May;39 Suppl 1:7-18. doi: 10.1111/liv.14093.
8
Cholangiocarcinoma.胆管癌。
Surg Clin North Am. 2019 Apr;99(2):315-335. doi: 10.1016/j.suc.2018.12.004. Epub 2019 Feb 10.
9
Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review.胆管癌的病理、分子及临床特征：综述
World J Gastrointest Oncol. 2022 Mar 15;14(3):607-627. doi: 10.4251/wjgo.v14.i3.607.
10
Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.胆管癌：解剖学位置相关的临床、预后及基因差异
Ann Transl Med. 2019 Dec;7(23):744. doi: 10.21037/atm.2019.12.37.

引用本文的文献

1
The EGFR Signaling Pathway Is Involved in the Biliary Intraepithelial Neoplasia Associated with Liver Fluke Infection.表皮生长因子受体（EGFR）信号通路参与与肝吸虫感染相关的胆管上皮内瘤变。
Pathogens. 2025 Jun 21;14(7):620. doi: 10.3390/pathogens14070620.
2
Exhaled volatile organic compounds for cholangiocarcinoma diagnosis.用于胆管癌诊断的呼出挥发性有机化合物
Liver Res. 2022 Sep 7;6(3):191-197. doi: 10.1016/j.livres.2022.09.001. eCollection 2022 Sep.
3
Comparative liver transcriptome analysis in hamsters infected with food-borne trematodes Opisthorchis felineus, Opisthorchis viverrini, or Clonorchis sinensis.

本文引用的文献

1
Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma.肝内胆管癌的分子亚型与精准肿瘤学
J Clin Med. 2021 Jun 25;10(13):2803. doi: 10.3390/jcm10132803.
2
Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.晚期胆管癌二线FOLFOX化疗与积极症状控制的对比研究（ABC-06）：一项3期、开放标签、随机对照试验
Lancet Oncol. 2021 May;22(5):690-701. doi: 10.1016/S1470-2045(21)00027-9. Epub 2021 Mar 30.
3
Biliary tract cancer.
感染食源性吸虫猫后睾吸虫、麝猫后睾吸虫或华支睾吸虫的仓鼠肝脏转录组比较分析。
PLoS Negl Trop Dis. 2024 Dec 9;18(12):e0012685. doi: 10.1371/journal.pntd.0012685. eCollection 2024 Dec.
4
Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities.华支睾吸虫相关胆管癌中的表观遗传生物标志物和 Wnt/β-连环蛋白通路：治疗机会的范围综述。
PLoS Negl Trop Dis. 2024 Sep 5;18(9):e0012477. doi: 10.1371/journal.pntd.0012477. eCollection 2024 Sep.
5
Network pharmacology- and cell-based assessments identify the FAK/Src pathway as a molecular target for the antimetastatic effect of momordin Ic against cholangiocarcinoma.基于网络药理学和细胞的评估确定黏着斑激酶/原癌基因酪氨酸蛋白激酶Src通路是苦瓜素Ic抗胆管癌转移作用的分子靶点。
Heliyon. 2024 Jun 3;10(11):e32352. doi: 10.1016/j.heliyon.2024.e32352. eCollection 2024 Jun 15.
6
Outcomes of liver resection in hepatitis C virus-related intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.丙型肝炎病毒相关肝内胆管癌肝切除的结果：一项系统评价和荟萃分析。
World J Virol. 2024 Mar 25;13(1):88946. doi: 10.5501/wjv.v13.i1.88946.
7
A Systematic Review and Meta-Analysis: Volatile Organic Compound Analysis in the Detection of Hepatobiliary and Pancreatic Cancers.一项系统评价与荟萃分析：挥发性有机化合物分析在肝胆胰癌检测中的应用
Cancers (Basel). 2023 Apr 14;15(8):2308. doi: 10.3390/cancers15082308.
胆道癌。
Lancet. 2021 Jan 30;397(10272):428-444. doi: 10.1016/S0140-6736(21)00153-7.
4
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.胆管癌 2020：机制和管理的新前沿。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.
5
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.ivosidenib 治疗 IDH1 突变、化疗耐药性胆管癌（ClarIDHy）：一项多中心、随机、双盲、安慰剂对照、3 期研究。
Lancet Oncol. 2020 Jun;21(6):796-807. doi: 10.1016/S1470-2045(20)30157-1. Epub 2020 May 13.
6
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.培米替尼治疗既往治疗过的局部晚期或转移性胆管癌：一项多中心、开放标签、2 期研究。
Lancet Oncol. 2020 May;21(5):671-684. doi: 10.1016/S1470-2045(20)30109-1. Epub 2020 Mar 20.
7
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.帕博利珠单抗治疗非结直肠癌高度微卫星不稳定/错配修复缺陷型癌症患者的疗效：来自 II 期 KEYNOTE-158 研究的结果。
J Clin Oncol. 2020 Jan 1;38(1):1-10. doi: 10.1200/JCO.19.02105. Epub 2019 Nov 4.
8
Trends in surgery and disparities in receipt of surgery for intrahepatic cholangiocarcinoma in the US: 2005-2014.美国肝内胆管癌手术趋势及手术接受情况差异：2005 - 2014年
J Gastrointest Oncol. 2019 Apr;10(2):339-347. doi: 10.21037/jgo.2018.12.07.
9
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.卡培他滨对比观察用于可切除胆管癌（BILCAP）：一项随机、对照、多中心、3 期研究。
Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25.
10
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.拉罗替尼在成人和儿童TRK融合阳性癌症中的疗效。
N Engl J Med. 2018 Feb 22;378(8):731-739. doi: 10.1056/NEJMoa1714448.